Explore evidence

75 %Most participants (75%) were willing to use an oral HIV self-test in the future.

KenyaVIH/sidapublished 2023AIDS carePubMeddocument of 5 observations

20 %About 20% of persons living with HIV aged 15–64 years did not know their HIV status in Kenya by 2018.

KenyaVIH/sidaobserved 2018published 2022BMC public healthPubMeddocument of 3 observations

16 %The proportion of adolescents and young people living with HIV on antiretroviral therapy with unsuppressed viral load who completed three enhanced adherence counselling sessions rose from 16% at baseline to 73% during the implementation period.

KenyaVIH/sidaobserved from March 2018 to February 2019published 2022BMJ open qualityPubMeddocument of 8 observations

42 individualsInterviews were conducted with 42 disengaged adolescents living with HIV in western Kenya from 2018 to 2020.

KenyaVIH/sidaobserved 2018 to 2020published 2021Journal of the International AIDS SocietyPubMeddocument of 4 observations

4.9 %The national HIV prevalence in Kenya was 4.9%.

KenyaVIH/sidaobserved 2018published 2021BMC public healthPubMeddocument of 17 observations

54 %Among people with a PrEP indication and an HIV test in the past 3 months, the median proportion of people on PrEP was 54% with DCP without cabotegravir.

KenyaVIH/sidapublished 2025The lancet. HIVPubMeddocument of 11 observations

55 %Among the 705 HIV patients, 55% were female.

KenyaVIH/sidapublished 2023BioMed research internationalPubMeddocument of 6 observations

6,180 ng/mLThe median nevirapine plasma concentration was 6180 ng/mL in HIV patients receiving nevirapine-based first-line antiretroviral therapy in Nairobi, Kenya.

KenyaVIH/sidapublished 2022MedicinePubMeddocument of 7 observations

11 %HIV was considered the cause of death in 11% of children.

KenyaVIH/sidapublished 2021PloS onePubMeddocument of 14 observations

2.35 aRRIn Siaya County, western Kenya, clients aged over 15 years who received home-based HIV testing between May 2016 and July 2017 showed an adjusted relative risk (aRR) of 2.35 for HIV-positive diagnosis among those who reported never having been tested for HIV.

KenyaVIH/sidaobserved May 2016 to July 2017published 2021BMC public healthPubMeddocument of 4 observations

10 %Four counties in Kenya reflected a generalized HIV epidemic, where HIV prevalence was more than 10% among the general population and more than 30% among key populations.

KenyaVIH/sidapublished 2024Journal of the International AIDS SocietyPubMeddocument of 5 observations

20 %Among 124 persons who sought PEP in a pilot study in five rural communities in Kenya and Uganda between December 2018 and May 2019, 20% reported exposure with a serodifferent partner.

Kenya · OugandaVIH/sidaobserved December 2018 to May 2019published 2021Journal of the International AIDS SocietyPubMeddocument of 11 observations

37 %La fréquence de la neuropathie périphérique était de 37 % chez les personnes vivant avec le VIH au Kenya selon l'étude de Mehta SA et al (2010).

KenyaVIH/sidaobserved 2010HAL · Unilimdocument of 747 observations

8.5 %Machine error rates for point-of-care HIV testing were 8.5% at birth and 2.5% at 6 weeks.

KenyaVIH/sidapublished 2020PloS onePubMeddocument of 13 observations

98.4 %Willingness to participate was similarly common among participants who enrolled (608/618, 98.4%) and completed the study (518/533, 97.2%).

KenyaVIH/sidaobserved From February 2017 to May 2018published 2026BMC public healthPubMeddocument of 10 observations

15.4 %Among 3567 HIV-1 partial pol sequences from antiretroviral-naive individuals in Kenya collected between 1986 and 2020, 550 (15.4%) had at least one pre-treatment HIV drug resistance mutation.

KenyaVIH/sidaobserved 1986–2020published 2024The Journal of antimicrobial chemotherapyPubMeddocument of 7 observations

2.7 %Of the 37 samples successfully sequenced, 1 (2.7%) sequence was identified as A1/G/AE and A1/C recombinants.

KenyaA1/G/AE and A1/C recombinants · VIH/sidapublished 2023Ethiopian journal of health sciencesPubMeddocument of 4 observations

99.7 %Of 8076 testing-eligible partners, 99.7% tested for HIV.

KenyaVIH/sidaobserved May 2018 to March 2020published 2025Sexually transmitted diseasesPubMeddocument of 9 observations

0.21 log10_copies_per_swab_per_monthGardnerella vaginalis decreased by 0.21 log10 copies per swab per month after DMPA exposure.

KenyaVIH/sidapublished 2016Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument of 8 observations

2,453 individualsAmong children and adolescents living with HIV in central Kenya, 2,453 (52.7%) were girls.

KenyaVIH/sidapublished 2022AIDS research and human retrovirusesPubMeddocument of 18 observations

80 %In the rural site in Kenya, 80% of adults with NTS bacteremia were HIV-infected from 2006 to 2009.

Kenyanon-Typhi Salmonella · VIH/sidaobserved 2006-2009published 2012PloS oneeurope_pmcdocument of 9 observationsDOI 10.1371/journal.pone.0031237

366 participantsThe prospective cohort study included 366 HIV-positive female sex workers followed monthly between October 2012 and March 2018 in Mombasa, Kenya.

KenyaVIH/sidaobserved October 2012 to March 2018published 2020PloS onePubMeddocument of 6 observations

60.6 %More than half (60.6%) of HIV-infected adolescents and young adults had a CD4 cell count higher than 500 cells/mm3.

KenyaVIH/sidapublished 2021African health sciencesPubMeddocument of 5 observations

5 %Among 437 pregnant women living with HIV in western Kenya, 5% reported concern about separation.

KenyaVIH/sidapublished 2020BMC pregnancy and childbirthPubMeddocument of 11 observations

24.3 %Index testing positivity yield was significantly higher than other testing modalities at 24.3% versus 1.3% in Nairobi County (p < 0.001).

KenyaVIH/sidapublished 2023Tropical medicine & international health : TM & IHPubMeddocument of 8 observations